Humana (NYSE:HUM) PT Lowered to $353.00

Humana (NYSE:HUM) had its price target lowered by Royal Bank of Canada from $415.00 to $353.00 in a report published on Thursday, Benzinga reports. The brokerage currently has an outperform rating on the insurance provider’s stock.

A number of other analysts have also recently commented on the stock. Wells Fargo & Company lowered their price objective on shares of Humana from $413.00 to $350.00 and set an overweight rating for the company in a research report on Monday, April 8th. TD Cowen lowered their price objective on shares of Humana from $427.00 to $396.00 and set a buy rating for the company in a research report on Tuesday, April 2nd. Jefferies Financial Group lowered their price objective on shares of Humana from $411.00 to $381.00 and set a buy rating for the company in a research report on Monday, April 22nd. Truist Financial restated a hold rating and issued a $550.00 price objective on shares of Humana in a research report on Friday, January 19th. Finally, Raymond James began coverage on shares of Humana in a research report on Friday, March 22nd. They issued a market perform rating for the company. Eleven equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of Hold and a consensus price target of $424.50.

Humana Stock Performance

HUM stock opened at $305.90 on Thursday. The business’s fifty day moving average is $327.77 and its 200-day moving average is $393.91. The company has a quick ratio of 1.59, a current ratio of 1.67 and a debt-to-equity ratio of 0.77. The company has a market cap of $36.86 billion, a P/E ratio of 19.05, a price-to-earnings-growth ratio of 1.79 and a beta of 0.45. Humana has a twelve month low of $299.23 and a twelve month high of $541.21.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. The company had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The firm’s quarterly revenue was up 10.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $9.38 EPS. Equities research analysts forecast that Humana will post 16.08 EPS for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.16%. The ex-dividend date is Friday, June 28th. Humana’s payout ratio is 22.04%.

Insider Activity

In related news, Director Jorge S. Mesquita acquired 545 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was bought at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the acquisition, the director now directly owns 2,578 shares of the company’s stock, valued at $946,358.02. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.32% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Humana

Several hedge funds have recently modified their holdings of the stock. Rakuten Securities Inc. acquired a new stake in Humana in the 4th quarter valued at about $25,000. Gradient Investments LLC lifted its stake in Humana by 200.0% in the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 40 shares during the last quarter. Cetera Trust Company N.A acquired a new stake in Humana in the 4th quarter valued at about $28,000. Private Wealth Management Group LLC acquired a new stake in Humana in the 4th quarter valued at about $32,000. Finally, Nvwm LLC lifted its stake in Humana by 41.0% in the 3rd quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after purchasing an additional 25 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.